Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor ...
5 hours ago
0
18
The Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. However, on May 7, 2024, the European Commission announced the vaccine is no longer authorized for use.
5 hours ago
0
14
Cancer is the second leading cause of death worldwide. In Europe, almost 3 in every 10 adults were diagnosed with a form of cancer in 2022.
5 hours ago
0
27
A new drug could prevent sepsis-related organ failure and death by restoring the health of a patient's blood vessels. Researchers from The University of Queensland and the Queensland Children's Hospital (QCH) have successfully ...
8 hours ago
0
9
A new review has found that taking zinc may help to reduce the duration of common cold symptoms by about two days, but the evidence is not conclusive and potential benefits must be balanced against side effects. The article ...
22 hours ago
0
0
Despite the high prevalence of substance abuse and its often devastating outcomes, especially among disadvantaged populations, few Americans receive treatment for substance use disorders. However, the rise of mobile health ...
May 8, 2024
0
17
Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors—an advance ...
May 8, 2024
0
11
A head-mounted device that generates an ultra-low frequency ultra-low magnetic field has been found to improve the symptoms of four male patients diagnosed with major depressive disorder. Future trials using the device may ...
May 8, 2024
0
20
Researchers at the Icahn School of Medicine at Mount Sinai have shed valuable light on the complex mechanisms by which a class of psychedelic drugs binds to and activates serotonin receptors to produce potential therapeutic ...
May 8, 2024
0
3
A team of Dana-Farber Cancer Institute investigators discovered that a subset of myeloid and lymphoid leukemias depend on a molecular complex called PI3Kgamma for survival. The study provides both mechanistic and preclinical ...
May 8, 2024
0
31
